This therapy is available as a new therapeutic option for localized prostate cancer which presents the advantages of a non-invasive treatment: precise local treatment in one session, repeatable if necessary low complication rate*, with a short period of hospitalization.
This treatment is recommended for patients with localized cancer (stage T1-T2) who are not candidates for a prostatectomy (because of their age, their general state of being or an associated disease) or patients who want an alternative to surgery. Additionally, this treatment can be used with patients who have local recurrence after external radiotherapy ("salvage" treatment).